Go to the Globe and Mail homepage

Jump to main navigationJump to main content

An exterior shot of Jean Coutu store in Longueuil, Quebec, May 2, 2012 (Christinne Muschi)

An exterior shot of Jean Coutu store in Longueuil, Quebec, May 2, 2012

(Christinne Muschi)

Stock Pick

Jean Coutu a stock with the right prescription Add to ...

Validea’s pick of the week provides a detailed report on a company that scores well in the stock-screening service’s model portfolios. On Validea.ca, investors can analyze 1,000 Canadian stocks through 12 different guru-based models and get individual reports on each company. Globe Investor has a distribution agreement with Validea.ca. Try it.

Quebec-based pharmacy retailer Jean Coutu Group Inc. operates 405 franchised stores across Québec, New Brunswick and Ontario under the banners of PJC Jean Coutu, PJC Clinique, PJC Santé and PJC Santé Beauté; also owns Pro Doc Ltd., which makes generic drugs. Its U.S. subsidiary merged with U.S. firm Rite Aid in 2007

It grew EPS by 32 per cent in most recent year, and has five-year growth rate of 11 per cent. JCP attracts strong interest from our Peter Lynch-based guru model because it trades for just 6.4 times TTM EPS and has 1.7 per cent dividend yield, which makes for a solid 0.5 yield-adjusted P/E-to-Growth ratio (using five-year growth rate).

With a very low debt/equity ratio of 2.9 per cent, JCP’s return on capital is 59.8 per cent, one reason it gets some interest from the Joel Greenblatt-based model. It also as averaged a return on equity of more than 30 per cent over past 3 years

Click here for the complete breakdown of Validea’s investing guru report.

Report Typo/Error

Follow us on Twitter: @GlobeInvestor

Next story




Most popular videos »

More from The Globe and Mail

Most popular